News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aerocrine: British National Institute for Clinical Excellence (NICE) Recommends the Use of FeNO Testing to Help Diagnose and Treat Asthma



11/8/2013 8:22:45 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine AB (STO:AERO-B) today announced that NICE (National Institute for Health and Clinical Excellence) this week has published draft guidelines recommending (http://www.nice.org.uk/newsroom/pressreleases/NICEConsultsOnDraftGuidanceRecommendingAsthmaTests.jsp) the use of Aerocrine’s NIOX MINO®and NIOX VERO® to guide the diagnosis and treatment of a type of asthma caused by airway inflammation.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES